Search Results 1011-1020 of 21701 for Inhibition

  1. Khashayarsha Khazaie, Ph.D. - Mayo Clinic Faculty Profiles

    Long Term Goals: To evaluate the therapeutic potential of combining bacterial vaccines with immune checkpoint inhibition and to understand the immunology of ...

  2. A Study to Evaluate the Safety and Effectiveness of APT-1011 to Treat Eosinophilic Esophagitis - Mayo Clinic

    Use of potent cytochrome P450 (CYP) 3A4 inhibitors (eg, ritonavir and ketoconazole) in the 12 weeks before Screening. Initiation of an elimination diet or ...

  3. A Study of IPI-926 for Patients with Myelofibrosis - Mayo Clinic

    Prior treatment with any inhibitor of the hedgehog pathway (e.g. GDC-0449); Received any treatment for myelofibrosis within 2 weeks of study entry; Other ...

  4. Familial Hypercholesterolemia Clinic - Overview

    Genetic counseling. Cardiology consultation. Lipid-lowering therapy, including statins, ezetimibe (Zetia) and PCSK9 inhibitors. Invasive cardiovascular testing ...

  5. A Study of Ramucirumab Plus Docetaxel in Patients With Urothelial Cancer - Mayo Clinic

    Prior treatment with no more than one prior immune checkpoint inhibitor is permitted and will not be considered as a line of systemic chemotherapy. Have ...

  6. Nephrotic syndrome - Diagnosis & treatment - Mayo Clinic

    Drugs called angiotensin-converting enzyme (ACE) inhibitors reduce blood pressure and the amount of protein released in urine. Medications in this category ...

  7. Obstetrics and Gynecology Clinical Trials - Medical Professionals

    The four cancer types are: Non-Small Cell Lung Cancer (NSCLC) and melanoma that are progressing on checkpoint inhibitor (CPI, generally refers to anti-PD(L) ...

  8. Cabozantinib and Nivolumab in Treating Patients With Advanced, Recurrent or Metastatic Endometrial Cancer - Mayo Clinic

    ... inhibitor does not have to necessary be the last line of treatment). ... inhibitors, antiplatelet agents (e.g., clopidogrel) or new oral anticoagulants ...

  9. Publications - Janhavi Athale, M.D. - Mayo Clinic

    Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer ...

  10. A Clinical Study To Test How Effective And Safe GLPG1690 Is For Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard Medical Treatment

    Currently taking medication known to be strong inhibitors of CYP3A4. ... Currently taking medication known to be potent inhibitors of P-gp. Acute IPF ...